Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLAMA
2024-513803-15-00Phase 4Authorised
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ibuprofen in acute myocarditis (2 arms), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Primary endpoint: Change in late gadolinium enhancement at 6 months. Planned start Jan 2025; status: authorised.
02
Drugs
ibuprofen
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on 2024-513803-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513803-15-00.